Norway
Diakonhjemmet is a Norwegian foundation with operations in education, health, and care. It was founded in 1890 and operates as a hospital, specialized university, and care provider. The Diakonhjemmet Hospital caters to approximately 135,000 inhabitants in Oslo, specializing in rheumatology, rheumatic surgery, and psychopharmacology. The hospital is also home to a national center for therapeutic drug monitoring and pharmacogenetic analyses. As the majority owner of VID Specialized University, Diakonhjemmet focuses on health, social, and church-related programs at bachelor's, master's, and Ph.D. levels, supported by extensive research.
The Diakonhjemmet Hospital Pharmacy is a leading provider of clinical pharmacy and pharmaceutical services, renowned for its Pharmaceutical Advisory Program. Additionally, Diakonhjemmet is venturing into the field of care and owns non-profit nursing homes and a home care service. With a strong presence in the education, health care, and pharmaceutical industries, Diakonhjemmet's diverse operations reflect its comprehensive approach to well-being.
Currently, there is no information available about the last investment or investors associated with Diakonhjemmet. However, its rich history and extensive contributions to the field of healthcare and education make it an intriguing potential investment opportunity for venture capitalists looking to support holistic, impactful initiatives in Norway and beyond.
